Publications

Showing 61–70 of 80 results from Publika

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS (2004)
Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients
J Am Soc Nephrol, 15 (4), 1029-37
PubMed 15034106 DOI 10.1097/01.asn.0000117977.14912.91
Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS (2004)
Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression
Kidney Int, 65 (4), 1492-8
PubMed 15086493 DOI 10.1111/j.1523-1755.2004.00530.x
Panuccio V, Tripepi R, Tripepi G, Mallamaci F, Benedetto FA, Cataliotti A, Bellanuova I, Giacone G, Malatino LS, Zoccali C (2004)
Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients
Am J Kidney Dis, 43 (3), 479-84
PubMed 14981606 DOI 10.1053/j.ajkd.2003.11.009
Schirger JA, Chen HH, Jougasaki M, Lisy O, Boerrigter G, Cataliotti A, Burnett JC (2003)
Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention
Circulation, 109 (2), 249-54
PubMed 14691038 DOI 10.1161/01.CIR.0000109139.69775.EB
Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, Iellamo D, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Malatino LS (2003)
Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease
J Am Soc Nephrol, 14 (10), 2611-7
PubMed 14514739 DOI 10.1097/01.asn.0000089026.28617.33
Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Malatino LS (2003)
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease
J Hypertens, 21 (7), 1355-62
PubMed 12817184 DOI 10.1097/00004872-200307000-00025
Jougasaki M, Leskinen H, Larsen AM, Luchner A, Cataliotti A, Tachibana I, Burnett JC (2003)
Ventricular cardiotrophin-1 activation precedes BNP in experimental heart failure
Peptides, 24 (6), 889-92
PubMed 12948841 DOI 10.1016/s0196-9781(03)00163-3
Chen HH, Redfield MM, Nordstrom LJ, Cataliotti A, Burnett JC (2003)
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure
Am J Physiol Renal Physiol, 284 (5), F1115-9
PubMed 12676739 DOI 10.1152/ajprenal.00337.2002
Tsuruda T, Jougasaki M, Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Lee SC, Salz-Gilman L, Nordstrom LJ, McGregor CG, Burnett JC (2003)
Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart
Regul Pept, 112 (1-3), 161-6
PubMed 12667638 DOI 10.1016/s0167-0115(03)00035-1
Jougasaki M, Leskinen H, Larsen AM, Cataliotti A, Chen HH, Burnett JC (2003)
Leukemia inhibitory factor is augmented in the heart in experimental heart failure
Eur J Heart Fail, 5 (2), 137-45
PubMed 12644003 DOI 10.1016/s1388-9842(02)00236-2